Faculty

National Academy of Medicine

Joan W. Miller, MD, FARVO Elected to the National Academy of Medicine

October 19, 2015

BOSTON (October 19, 2015) -- Joan Whitten Miller, MD, Henry Willard Williams Professor of Ophthalmology and Chair of Ophthalmology at Harvard Medical School, and Chief of Ophthalmology at Massachusetts Eye and Ear and Massachusetts General Hospital, has been elected to membership in the prestigious National Academy of Medicine (NAM). Dr. Miller is an internationally recognized expert on retinal disorders, including age-related macular...

Read more about Joan W. Miller, MD, FARVO Elected to the National Academy of Medicine
ONL Therapeutics Announces Formation of Scientific Advisory Board

ONL Therapeutics Announces Formation of Scientific Advisory Board

October 14, 2015

ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, has announced that Joan W. Miller, MD, Chair of the Department of Ophthalmology, Harvard Medical School and Chief of Ophthalmology at Massachusetts Eye and Ear and Massachusetts General Hospital, is one of five of the world’s premier retinal disease thought leaders who will serve on its newly formed scientific advisory board (SAB). The goal of...

Read more about ONL Therapeutics Announces Formation of Scientific Advisory Board
Jason Comander and Leo Kim discuss vision research with members of Congress

Jason Comander and Leo Kim discuss vision research with members of Congress

October 13, 2015

On October 7th and 8th, Jason Comander, MD, PhD, and Leo Kim, MD, PhD, participated in the Alliance for Eye and Vision Research (AEVR) Emerging Vision Scientists Program. This program allows scientists to meet with members of Congress to discuss the importance of vision research in the continuing fight to prevent blindness. 

Dr...

Read more about Jason Comander and Leo Kim discuss vision research with members of Congress
Researchers Resurrect Ancient Viruses in Hopes of Improving Gene Therapy

Researchers Resurrect Ancient Viruses in Hopes of Improving Gene Therapy

July 30, 2015

Boston, MA Researchers at Massachusetts Eye and Ear and Schepens Eye Research Institute have reconstructed an ancient virus that is highly effective at delivering gene therapies to the liver, muscle, and retina. This discovery, published July 30 in Cell Reports, could potentially be used to design gene therapies that are not only safer and more potent than therapies currently...

Read more about Researchers Resurrect Ancient Viruses in Hopes of Improving Gene Therapy
Lloyd Paul Aiello

Comparing Diabetic Macular Edema Treatments

February 19, 2015

Results of the DRCR.net Protocol T Study 

In the first clinical trial directly comparing three drugs most commonly used to treat diabetic macular edema, researchers found all were effective in improving vision and preventing vision loss. However, one drug, aflibercept, provided greater improvement for people with more severe vision loss when treatment was initiated. The trial was conducted by the...

Read more about Comparing Diabetic Macular Edema Treatments
Panel-based Genetic Diagnostic Testing for Eye Disease

Panel-based Genetic Diagnostic Testing for Eye Disease

December 1, 2014

Researchers Report that Panel-based Genetic Diagnostic Testing for Inherited Eye Diseases is Highly Accurate and More Sensitive than Exome Sequencing
Findings published online in Genetics in Medicine

Contact: Mary Leach 

BOSTON, MASS. (Nov. 20, 2014) --Investigators at Massachusetts Eye and Ear and Harvard Medical School Department of Ophthalmology and colleagues reported the development and characterization of a...

Read more about Panel-based Genetic Diagnostic Testing for Eye Disease

Pages